Publicacions (41) Publicacions de SANDRA MUNTION OLAVE

2023

  1. Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease

    Nutrients, Vol. 15, Núm. 21

  2. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution

    eLife, Vol. 12

2022

  1. Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells

    Therapeutic Advances in Hematology, Vol. 13

  2. Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia

    Frontiers in Bioengineering and Biotechnology, Vol. 10

  3. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes

    Nature Communications, Vol. 13, Núm. 1

2021

  1. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

    CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535

  2. Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo

    Stem Cell Research and Therapy, Vol. 12, Núm. 1

  3. Improving hematopoietic engraftment: Potential role of mesenchymal stromal cell-derived extracellular vesicles

    Stem Cells, Vol. 39, Núm. 1, pp. 26-32

  4. MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients

    Stem Cell Research and Therapy, Vol. 12, Núm. 1

  5. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

    Nature Communications, Vol. 12, Núm. 1

2019

  1. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up

    Stem Cell Research and Therapy, Vol. 10, Núm. 1

  2. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

    British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104

  3. The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34+ Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability

    Stem Cells, Vol. 37, Núm. 10, pp. 1357-1368

2018

  1. Biocompatibility of two model elastin-like recombinamer-based hydrogels formed through physical or chemical cross-linking for various applications in tissue engineering and regenerative medicine

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 12, Núm. 3, pp. e1450-e1460

  2. Human bone marrow mesenchymal stromal cells promote bone regeneration in a xenogeneic rabbit model: A preclinical study

    Stem Cells International, Vol. 2018

  3. Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability

    Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 3, pp. 443-451

2017

  1. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: A new therapeutic target?

    Oncotarget, Vol. 8, Núm. 17, pp. 28187-28202

  2. Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis

    PLoS ONE, Vol. 12, Núm. 8

  3. Regeneration of hyaline cartilage promoted by xenogeneic mesenchymal stromal cells embedded within elastin-like recombinamer-based bioactive hydrogels

    Journal of Materials Science: Materials in Medicine, Vol. 28, Núm. 8

2016

  1. Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting

    European Journal of Haematology, Vol. 97, Núm. 6, pp. 528-537